Key result
Activation of perivascular mast cells in apolipoprotein E-deficient mice promoted robust plaque expansion and destabilization, which was prevented by treatment with the mast cell stabilizer cromolyn.
Why the study?
Does mast cell activation promote atherogenesis and plaque destabilization, and can it be prevented by cromolyn in apolipoprotein E-deficient mice?
Does mast cell activation promote atherogenesis and plaque destabilization, and can it be prevented by cromolyn in apolipoprotein E-deficient mice?
Mast cell activation promotes atherogenesis and plaque destabilization in vivo, suggesting that mast cell stabilization could be a novel therapeutic approach to prevent acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Mast cell stabilization should not yet change practice; hypothesis-generating for plaque stabilization in humans.
BACKGROUND: Mast cells are major effector cells in allergy and host defense responses. Their increased number and state of activation in perivascular tissue during atherosclerosis may point to a role in cardiovascular disorders. In the present study, we investigated the contribution of perivascular mast cells to atherogenesis and plaque stability in apolipoprotein E-deficient mice. METHODS AND RESULTS: We show here that episodes of systemic mast cell activation during plaque progression in mice leads to robust plaque expansion. Targeted activation of perivascular mast cells in advanced plaques sharply increases the incidence of intraplaque hemorrhage, macrophage apoptosis, vascular leakage, and CXCR2/VLA-4-mediated recruitment of leukocytes to the plaque. Importantly, treatment with the mast cell stabilizer cromolyn does prevent all the adverse phenomena elicited by mast cell activation. CONCLUSIONS: This is the first study to demonstrate that mast cells play a crucial role in plaque progression and destabilization in vivo. We propose that mast cell stabilization could be a new therapeutic approach to the prevention of acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Bot et al. (2007) studied Atherosclerosis. Cromolyn was evaluated on Plaque progression and destabilization. Activation of perivascular mast cells in apolipoprotein E-deficient mice promoted robust plaque expansion and destabilization, which was prevented by treatment with the mast cell stabilizer cromolyn.
Synapse has enriched 10 related papers. Consider them for comparative context: